Decorated Polyetheretherketone Implants with Antibacterial and Antioxidative Effects through Layer-by-Layer Nanoarchitectonics Facilitate Diabetic Bone Integration with Infection
Source abstract
Abstract
Patients suffering diabetic bone defects still need some new and effective strategies to achieve enhanced prognostic effects. Although medical implants are the common treatment of bone defects, the excessive oxidative stress and high risk of bacterial infection in diabetes mellitus lead to a higher risk of implant failure. To improve the healing ability of diabetic bone defects, herein, polyetheretherketone (PEEK) was modified through a developed layer-by-layer (LBL) construction strategy to obtain multifunctional PEEK (SP@(TA-GS/PF)*3) by the assembly of tannic acid (TA), gentamicin sulfate (GS) and Pluronic F127 (PF127) on the basis of prepared porous PEEK through sulfonation (SPEEK). The prepared SP@(TA-GS/PF)*3 exhibited sustained antimicrobial activity and enhanced the differentiation of osteoblast (MC3T3-E1) for needed osteogenesis. Moreover, SP@(TA-GS/PF)*3 scavenged excessive oxidative stress to promote the growth of H 2 O 2 damaged HUVEC with enhanced secretion of VEGF for neovascularization. In addition, the remarkable in vivo outcomes of angiogenesis and osseointegration were revealed by the subcutaneous implant model and bone tissue implant model in diabetic rats, respectively. The in vitro and in vivo results demonstrated that modified PEEK with multifunction can be an attractive tool for enhancing bone integration under diabetic conditions, underpinning the clinical application potential of modified implants for diabetic osseointegration.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Multimedia Communication and Technology · FinTech, Crowdfunding, Digital Finance
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Orthopedic Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, China
Department of Orthopedic Surgery, Shengli Clinical Medical College of Fujian Medical University, Jinshan Hospital of Fujian Provincial Hospital, Fuzhou, 350001, China
Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China
Funding
Natural Science Foundation of Fujian Province · Medical Innovation Program of Fujian Province
References (69)
Show source-provided references
1. 10.1016/j.actbio.2020.07.06210.1016/j.actbio.2020.07.062 ↗
2. 10.1016/j.addr.2015.03.01310.1016/j.addr.2015.03.013 ↗
3. 10.1007/s40610-016-0046-210.1007/s40610-016-0046-2 ↗
4. 10.1016/j.jos.2016.01.00710.1016/j.jos.2016.01.007 ↗
5. 10.1016/j.diabres.2018.02.02310.1016/j.diabres.2018.02.023 ↗
6. 10.1016/j.actbio.2021.09.05310.1016/j.actbio.2021.09.053 ↗
7. 10.1038/nrendo.2011.23310.1038/nrendo.2011.233 ↗
8. 10.1016/j.bioactmat.2020.08.03010.1016/j.bioactmat.2020.08.030 ↗
9. 10.1089/ten.teb.2016.037010.1089/ten.teb.2016.0370 ↗
10. 10.1007/s00223-019-00576-310.1007/s00223-019-00576-3 ↗
11. 10.1146/annurev-pharmtox-011112-14032010.1146/annurev-pharmtox-011112-140320 ↗
12. 10.1016/j.imbio.2018.11.01010.1016/j.imbio.2018.11.010 ↗
13. 10.1088/1748-605X/abaaa110.1088/1748-605X/abaaa1 ↗
14. 10.1016/j.cellsig.2012.01.00810.1016/j.cellsig.2012.01.008 ↗
15. 10.1016/j.bone.2014.09.01710.1016/j.bone.2014.09.017 ↗
16. 10.1021/acsami.1c2346110.1021/acsami.1c23461 ↗
17. 10.1016/j.biomaterials.2018.03.02410.1016/j.biomaterials.2018.03.024 ↗
18. 10.2106/JBJS.J.0193510.2106/JBJS.J.01935 ↗
19. 10.4093/dmj.2019.007110.4093/dmj.2019.0071 ↗
20. 10.1371/journal.pone.009530010.1371/journal.pone.0095300 ↗
21. 10.1039/C7TB03247A10.1039/C7TB03247A ↗
22. 10.1016/j.ijpharm.2021.12066210.1016/j.ijpharm.2021.120662 ↗
23. 10.1021/acs.chemmater.0c0029010.1021/acs.chemmater.0c00290 ↗
24. 10.1016/j.mattod.2020.12.01810.1016/j.mattod.2020.12.018 ↗
25. 10.1016/j.biomaterials.2013.01.07410.1016/j.biomaterials.2013.01.074 ↗
26. 10.1016/j.ijbiomac.2021.02.13610.1016/j.ijbiomac.2021.02.136 ↗
27. 10.1002/advs.20210036810.1002/advs.202100368 ↗
28. 10.1021/acs.iecr.0c0210710.1021/acs.iecr.0c02107 ↗
29. 10.1016/j.biomaterials.2020.12046410.1016/j.biomaterials.2020.120464 ↗
30. 10.1016/j.bioactmat.2021.02.02310.1016/j.bioactmat.2021.02.023 ↗
31. 10.1002/advs.20210177810.1002/advs.202101778 ↗
32. 10.1002/adfm.20210137210.1002/adfm.202101372 ↗
33. 10.1016/j.bioactmat.2020.12.01910.1016/j.bioactmat.2020.12.019 ↗
34. 10.1016/j.msec.2019.03.07810.1016/j.msec.2019.03.078 ↗
35. 10.1002/adhm.20210079310.1002/adhm.202100793 ↗
36. 10.1039/D1RA07657D10.1039/D1RA07657D ↗
37. 10.3390/ijms2209461410.3390/ijms22094614 ↗
38. 10.1039/D1TB02073K10.1039/D1TB02073K ↗
39. 10.1007/s12274-021-3626-210.1007/s12274-021-3626-2 ↗
40. 10.1002/adfm.20191002110.1002/adfm.201910021 ↗
41. 10.1016/j.jmst.2020.10.06610.1016/j.jmst.2020.10.066 ↗
42. 10.1080/10717544.2021.196092410.1080/10717544.2021.1960924 ↗
43. 10.1016/j.msec.2020.11078210.1016/j.msec.2020.110782 ↗
44. 10.1016/j.actbio.2021.05.00910.1016/j.actbio.2021.05.009 ↗
45. 10.1039/D0NH00680G10.1039/D0NH00680G ↗
46. 10.1246/bcsj.2021008910.1246/bcsj.20210089 ↗
47. 10.1039/D1CP04669A10.1039/D1CP04669A ↗
48. 10.1016/j.molliq.2020.11359110.1016/j.molliq.2020.113591 ↗
49. 10.1016/j.ijpharm.2006.07.03910.1016/j.ijpharm.2006.07.039 ↗
50. 10.1016/j.msec.2021.11210910.1016/j.msec.2021.112109 ↗
51. 10.1016/j.compositesb.2017.07.01010.1016/j.compositesb.2017.07.010 ↗
52. Pei Y. H. · 2015
53. 10.1021/acsnano.0c0607810.1021/acsnano.0c06078 ↗
54. 10.1016/j.xinn.2021.10014810.1016/j.xinn.2021.100148 ↗
55. 10.1016/j.jcis.2020.01.00710.1016/j.jcis.2020.01.007 ↗
56. 10.1177/2309499021105149210.1177/23094990211051492 ↗
57. 10.1136/bcr-2015-21137610.1136/bcr-2015-211376 ↗
58. 10.1016/j.compositesb.2021.10956910.1016/j.compositesb.2021.109569 ↗
59. 10.1039/C9BM01158G10.1039/C9BM01158G ↗
60. 10.1016/j.cej.2021.13149010.1016/j.cej.2021.131490 ↗
61. 10.1126/sciadv.abd674010.1126/sciadv.abd6740 ↗
62. 10.1007/s11914-015-0286-810.1007/s11914-015-0286-8 ↗
63. 10.1007/s00125-019-4865-610.1007/s00125-019-4865-6 ↗
64. 10.1161/CIRCRESAHA.110.22354510.1161/CIRCRESAHA.110.223545 ↗
65. 10.1152/physiol.00039.201610.1152/physiol.00039.2016 ↗
66. 10.1038/s41419-017-0135-z10.1038/s41419-017-0135-z ↗
67. 10.1159/00034510710.1159/000345107 ↗
68. 10.1016/j.biomaterials.2020.12053410.1016/j.biomaterials.2020.120534 ↗
69. 10.7717/peerj.1295110.7717/peerj.12951 ↗